{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:09:34Z","timestamp":1770142174661,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.clml.2022.12.005","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:23:05Z","timestamp":1670332985000},"page":"e125-e129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrent Mantle Cell Lymphoma Isolated to the Testis After 19-Year Remission: A Case Report and Review of the Literature"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3907-9409","authenticated-orcid":false,"given":"Cassie","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Baine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8391-390X","authenticated-orcid":false,"given":"Kurt W.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James O.","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4084-8714","authenticated-orcid":false,"given":"Charles A.","family":"Enke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2022.12.005_bib0001","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.biocel.2007.04.026","article-title":"The cellular origin of mantle cell lymphoma","volume":"39","author":"Bertoni","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.clml.2022.12.005_bib0002","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ajh.26523","article-title":"Mantle cell lymphoma in 2022\u2014A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments","volume":"97","author":"Jain","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2022.12.005_bib0003","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ajh.24797","article-title":"Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management","volume":"92","author":"Vose","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2022.12.005_bib0004","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0002-9440(10)65399-0","article-title":"Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization","volume":"154","author":"Li","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clml.2022.12.005_bib0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"P\u00e9rez-Gal\u00e1n","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.12.005_bib0006","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.12.005_bib0007","first-page":"44","article-title":"Mantle cell lymphoma: state of the art","volume":"13","author":"Skarbnik","year":"2015","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.clml.2022.12.005_bib0008","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21037\/aol.2019.11.04","article-title":"Recent advances in the first-line treatment of mantle cell lymphoma","volume":"4","author":"Cheminant","year":"2020","journal-title":"Ann Lymphoma"},{"key":"10.1016\/j.clml.2022.12.005_bib0009","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1914347","article-title":"KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma","volume":"382","author":"Wang","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clml.2022.12.005_bib0010","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1080\/10428190701302442","article-title":"Mantle cell lymphoma with a rare involvement of the testicle","volume":"48","author":"Iwuanyanwu","year":"2007","journal-title":"Leukemia Lymphoma"},{"key":"10.1016\/j.clml.2022.12.005_bib0011","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00277-010-1049-3","article-title":"Primary mantle cell lymphoma of the testis","volume":"90","author":"Licci","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2022.12.005_bib0012","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.clml.2011.06.013","article-title":"Testis-isolated mantle cell lymphoma: a unique case","volume":"11","author":"Epstein","year":"2011","journal-title":"Clin Lymphoma Myeloma Leukemia"},{"key":"10.1016\/j.clml.2022.12.005_bib0013","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/ejh.12344","article-title":"Mantle cell lymphoma and diffuse large B-cell lymphoma of the testis: a unique case of composite non-Hodgkin lymphoma","volume":"93","author":"Andhavarapu","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2022.12.005_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-239014","article-title":"Extranodal blastoid\/pleomorphic variant of mantle cell lymphoma involving the testis and skin","volume":"14","author":"Anusim","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clml.2022.12.005_bib0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PAI.0b013e3181bb9edf","article-title":"BCL6, MUM1, and CD10 expression in mantle cell lymphoma","volume":"18","author":"Gualco","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.clml.2022.12.005_bib0016","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1182\/blood-2007-10-118794","article-title":"Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas","volume":"111","author":"Wlodarska","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2022.12.005_bib0017","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/jcp.2007.048629","article-title":"Mantle cell lymphoma lacking the t(11;14) translocation: a case report and brief review of the literature","volume":"61","author":"Hunt","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clml.2022.12.005_bib0018","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.3324\/haematol.2019.237073","article-title":"Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma","volume":"105","author":"Carla","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2022.12.005_bib0019","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00428-015-1840-6","article-title":"Mantle cell lymphoma\u2014a spectrum from indolent to aggressive disease","volume":"468","author":"Sander","year":"2016","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.clml.2022.12.005_bib0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/cyto.b.20590","article-title":"A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma","volume":"80B","author":"Medd","year":"2011","journal-title":"Cytometry Part B"},{"key":"10.1016\/j.clml.2022.12.005_bib0021","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1158\/0008-5472.CAN-15-1370","article-title":"Mechanisms of cancer cell dormancy\u2014another hallmark of cancer?","volume":"75","author":"Yeh","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.clml.2022.12.005_bib0022","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3793","article-title":"Mechanisms of disseminated cancer cell dormancy: an awakening field","volume":"14","author":"Sosa","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clml.2022.12.005_bib0023","series-title":"Proceedings of the National Academy of Sciences","first-page":"12396","article-title":"Controversies in clinical cancer dormancy","volume":"108","author":"Uhr","year":"2011"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265022017505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265022017505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:41:51Z","timestamp":1761871311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265022017505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2152265022017505"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2022.12.005","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent Mantle Cell Lymphoma Isolated to the Testis After 19-Year Remission: A Case Report and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2022.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}